MMSN

We thought #WAD2025 would be a good day to launch @MMSNIG YouTube Channel. Like, Share and Subscribe! #thinkfungal And stay tuned for the winners of our World Aspergillosis Day Video Challenge youtu.be/xmAAqIbbiM8?si…

linkedin.com/posts/medical-… Happy International Women's Day to all the 'Fun Gals' of medical mycology

Important synthesis on pulmonary #fungal infections

@forestcita Important synthesis!

My recent contribution to Current opinion in pulmonary medicine to rise awareness about fungal infections in the context of two current global challenges in medicine. pubmed.ncbi.nlm.nih.gov/41733150/ 

#Fusariosis #Invasive mild disease

Trichophyton rubrum complex microculture. This one took longer to produce the classic morphology and had lesser microconidia than other isolated strains we've seen

@Rommiemicologia Beautiful!

🔥📰Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification @JClinMicro Great collaboration with @IbrahimLab3 🙏@jprattes @SarahSedik @lagrou_katrien @JeffreyJenks5 @RobinaAerts @MatthiasEgger11 journals.asm.org/doi/10.1128/jc…

@gaffi_org inaugural Africa Fungal Disease Summit takes place at @AfricaCDC from March 2nd to 4th in Addis Ababa. Wishing @RitaOladele (always represents the @MMSNIG and @Pamwg_1), @BrightOcansey1 and other #fun guys and #fun gals fruitful deliberations!

Mucormycosis is a rapidly progressive, invasive fungal infection that causes severe disease. The latest epidemiologic data, risk factors, diagnostic strategies, and treatment approaches are discussed in a new review. 👉 nej.md/3ZsLZ21 Early diagnosis and initiation of antifungal therapy significantly reduce mortality among patients with mucormycosis and hematologic cancers, from approximately 80% to 40%. Accurate diagnosis of mucormycosis begins at the bedside with evaluation of symptoms and signs in patients at high risk (seen in figure). Although early symptoms and physical findings in patients with mucormycosis are often nonspecific, they carry important diagnostic significance in patient populations with high risk. Periorbital cellulitis, diplopia, focal palatal necrosis, and necrotic wounds in patients at high risk should cause serious concern for mucormycosis and lead to prompt assessment. Maintaining a high index of suspicion for mucormycosis in such patients can be the impetus for obtaining fluids and tissues for diagnostic analysis, ordering imaging procedures, initiating antifungal therapy, requesting surgical assessment, reversing immunodeficiencies, and correcting metabolic abnormalities. Learn more in the Review Article “Mucormycosis” by Dimitrios P. Kontoyiannis, MD, ScD, and Thomas J. Walsh, MD, from the University of Texas M.D. Anderson Cancer Center (@MDAndersonNews), Center for Innovative Therapeutics and Diagnostics, and University of Maryland School of Medicine (@UMmedschool): nej.md/3ZsLZ21

#IFI diagnostics have come a long way since the advent of rapid testslike @IMMYdiagnostics' CrAg LFA. Simplicity does not obviate the need for training. This technical note underscores strict compliance with manufacturers instructions. lnkd.in/dH2HMH5m

Better diagnostic tools, and early diagnosis and treatment are needed to improve care for patients. cdc.gov/fungal/

Mycetoma can lead to limb amputation after the infection invades the bone. bit.ly/470hDHa Without treatment chromoblastomycosis can cause skin cancer. Untreated sporotrichosis can spread to the lungs and brain, leading to death.

#World #NTD day! Let's not forget the most neglected of them- #mycetoma #chromoblastomycosis #sporotrichosis Read @MMSNIG communique linkedin.com/posts/medical-…

Treatment of pulmonary mucormycosis: current concepts doi.org/10.1080/147872…

🦠🌍 #Candidozyma_auris (formerly #Candida_auris) is a rising @WHO priority pathogen 🚨 Multidrug-resistant, ICU-driven and hard to eradicate 🏥🧬 This review maps global spread, outbreaks, resistance and infection prevention control gaps 🔍🧼 clinicalmicrobiologyandinfection.org/action/showPdf…

Invasive fungal diseases are a growing global health concern, with Candidozyma auris (formerly Candida auris) emerging as a major healthcare-associated pathogen 🆕⚡ Narrative Review::: Candidozyma auris (formerly Candida auris): Resistant, long-lasting, and everywhere #IDXposts clinicalmicrobiologyandinfection.org/article/S1198-…

Happy Holidays to our members and collaborators. We hope you enjoy this time with your loved ones and are refreshed in the new year to continue the good work of tackling fungal diseases.

When cough won’t stop even after TB treatment, it’s time to widen the lens. Fungal diseases like #CPA often mimic or coexist TB. To truly strengthen TB programs,we must integrate fungal disease screening into routine practice. 🔍#StopTB. #thinkfungal #Mycology #AMR #PulmonaryCare

Let's raise the decibel on the contribution of fungi to #AMR #WAAW2025 #thinkfungud sciencedirect.com/science/articl…